Treatment outcomes and risk factors for severity and mortality in Clostridioides difficile infection: a single-center study in Thailand.|https://dx.doi.org/10.3855/jidc.20742
Fecal Microbiota-based therapies compared to Fecal Microbiota Transplantation for Preventing recurrent C. difficile Infection.|https://dx.doi.org/10.1016/j.cgh.2025.08.029
Bezlotoxumab for the prevention of recurrent Clostridioides difficile infection for patients with cancer.|https://dx.doi.org/10.20524/aog.2025.0994
